---
type: open-question
sweep_date: 2026-05-20
sweep_sha: 6437cb4
section_index: 1
global_index: 8
pass3_verdict: Confirmed
overlap_tag: EXTENSION
---

# Does the corpus's documented pattern — genetic variant → pathway vulnerability → intervention class that bypasses the vulnerability → genotype-stratified recommendation — generalize beyond Q141K × butyrate?

1. **Does the corpus's documented pattern — genetic variant → pathway vulnerability → intervention class that bypasses the vulnerability → genotype-stratified recommendation — generalize beyond Q141K × butyrate?** The Q141K × butyrate × HDAC rescue pattern is the most-developed instance of this pattern in the wiki (documented across `abcg2-modulators.md` §6, `purine-degrading-bacteria.md` §"Q141K + PDB-butyrate + HDAC," `gout-genetic-variants.md` §Category 1, and `genotype-informed-supplement-workflow.md` Q141K worked example). Connection 2 above identifies CFH Y402H × dietary CP0 as a second instance. Are there additional unnamed instances? Candidates to check: URAT1 W258X carriers × siRNA-URAT1 or uricosuric emphasis (protective variant — different direction, but same pattern logic: variant → transporter phenotype → intervention match); NLRP3 CAPS variants × CP2-CP4 emphasis (gain-of-function inflammasome → upweight direct NLRP3 inhibitors over upstream priming interventions); HLA-B*58:01 carriers × non-XO-inhibitor urate-lowering emphasis (pharmacogenetic contraindication → re-route through gut-lumen sink or alternative uricosurics). This is a platform-level pattern that, if named, would convert the genotype-informed-supplement-workflow from a single-instance workflow into a *pattern library* with each variant having a named bypass-intervention class. A focused desk audit across `gout-genetic-variants.md` categories 1–7 to identify every variant with a named intervention class that bypasses the variant's mechanism would produce this pattern library.

> **Pass 3 review — Confirmed.** `[OVERLAP: EXTENSION]` This is a useful abstraction: the corpus already has the Q141K × butyrate template in `abcg2-modulators.md` and `genotype-informed-supplement-workflow.md`, and `gout-genetic-variants.md` already lists other variants whose mechanisms route naturally to intervention classes. Pass 2’s contribution is to name the reusable pattern library rather than leaving it as one-off variant notes. Chokepoint-fit is strong across urate-disposal nodes, CP0, and CP2–CP6; chassis assignment should remain downstream and include chassis-pending modalities such as siRNA-URAT1, mRNA/IL-1RA, and pharmacological chaperones.

---

## ✓ Actioned 2026-05-22

**Pattern library framework added** to `genotype-informed-supplement-workflow.md` 2026-05-22 as a new section — "Pattern library — variant → pathway vulnerability → bypass intervention." Names the pattern explicitly + lists three confirmed instances (Q141K × butyrate, OCTN1 × EGT, CFH Y402H × dietary CP0) + three unaudited candidate instances queued as Phase 2 audit work (URAT1 W258X × uricosurics/siRNA-URAT1; NLRP3 CAPS × CP2-CP4 direct inhibitors; HLA-B*58:01 × non-XO-inhibitor ULT). Includes "How to use the pattern" sub-block for application to future variants and "What the pattern does NOT claim" softening with the CFH × AMD counter-evidence as the canonical case where the pattern's prediction is empirically gated.

Pass 3's "useful abstraction; corpus already has the Q141K × butyrate template + gout-genetic-variants.md lists other variants whose mechanisms route naturally" is implemented verbatim — the abstraction is named, the template is generalized, and the unaudited candidates are queued for the next pattern-library expansion pass.

No new `gout-genetic-variants.md` audit landed this walk (deferred as Phase 2 — each unaudited candidate needs its own focused desk pass to confirm the bypass-intervention identification). The framework now exists for future audits to populate.

Closure complete.
